Article
Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia
4 Nov 2015
Abstract excerpt
Acute lymphoblastic leukemia (ALL) has been generally considered a genetic disease (disorder) with an aggressive tumor entity of highly proliferative malignant lymphoid cells. However, in recent years, significant advances have been made in the elucidation of the ALL-associated processes. Thus, we understand that histone acetylation is involved in the permanent changes of gene expression controlling ALL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
